Tuoxin Pharmaceuticals: Wholly owned subsidiary obtains NSF 173 GMP DI certification.

On March 4th, Tuoxin Pharmaceuticals announced that its wholly-owned subsidiary, Jingquan Biotechnology, has officially passed the NSF 173 GMP DI certification recently. This indicates that the company has passed the strict quality and safety audits of NSF and meets the good manufacturing practice requirements set by the US federal regulations for raw material production enterprises.